<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33367784</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1945-7197</ISSN><JournalIssue CitedMedium="Internet"><Volume>106</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>25</Day></PubDate></JournalIssue><Title>The Journal of clinical endocrinology and metabolism</Title><ISOAbbreviation>J Clin Endocrinol Metab</ISOAbbreviation></Journal><ArticleTitle>HLA Class I Upregulation and Antiviral Immune Responses in Graves Disease.</ArticleTitle><Pagination><StartPage>e1763</StartPage><EndPage>e1774</EndPage><MedlinePgn>e1763-e1774</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1210/clinem/dgaa958</ELocationID><Abstract><AbstractText Label="CONTEXT">The origin of Graves disease (GD) remains elusive. However, evidence of an association between GD and viral infections is emerging. Human leukocyte antigen (HLA) class I presents viral antigens to circulating immune cells and plays a crucial role in the defense against viral infections.</AbstractText><AbstractText Label="OBJECTIVE">This work aimed to investigate HLA class I expression, enterovirus presence, and the viral immune response proteins signal transducer and activation of transcription 1 (STAT1) and protein kinase R (PKR) in thyroid tissue from GD patients.</AbstractText><AbstractText Label="METHODS">We collected thyroid tissue from core needle biopsies or surgical specimens from 48 GD patients and 24 controls. Standard immunohistochemistry was used to detect HLA class I and enteroviral capsid protein 1 (VP1) on formalin-fixed and paraffin-embedded tissue. STAT1 and PKR were examined by combined immunofluorescence staining. HLA class I expression score was the main outcome measure.</AbstractText><AbstractText Label="RESULTS">The HLA class I expression score, which takes both proportion and intensity of immunostaining into account, was significantly higher in GD patients (3.1&#x2005;&#xb1;&#x2005;3.3) than in controls (0.5&#x2005;&#xb1;&#x2005;0.9) (P&#x2005;&lt;&#x2005;.001). Significantly more VP1 positive thyroid cells were found GD samples (50.1&#x2005;&#xb1;&#x2005;30.5%) than in controls (14.9&#x2005;&#xb1;&#x2005;10.5%) (P&#x2005;&lt;&#x2005;.001). STAT1 and HLA class I were found within the same thyroid cells and PKR and VP1 were also colocalized within thyroid cells.</AbstractText><AbstractText Label="CONCLUSION">HLA class I is upregulated in GD and enterovirus protein is prevalent in thyroid tissue. The colocalization of HLA class I with STAT1 and VP1 with PKR indicates an antiviral tissue response. These findings support the concept of a link between viral infections and GD.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weider</LastName><ForeName>Therese</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Oslo, Faculty of Medicine, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richardson</LastName><ForeName>Sarah J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Islet Biology Exeter, Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>Noel G</ForeName><Initials>NG</Initials><AffiliationInfo><Affiliation>Islet Biology Exeter, Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paulsen</LastName><ForeName>Trond H</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Department of Breast and Endocrine Surgery, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahl-J&#xf8;rgensen</LastName><ForeName>Knut</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The University of Oslo, Faculty of Medicine, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammerstad</LastName><ForeName>Sara Salehi</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Specialist Center Pilestredet Park, Oslo, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Endocrinol Metab</MedlineTA><NlmUniqueID>0375362</NlmUniqueID><ISSNLinking>0021-972X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015395">Histocompatibility Antigens Class I</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006111" MajorTopicYN="Y">Graves Disease</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015395" MajorTopicYN="N">Histocompatibility Antigens Class I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007109" MajorTopicYN="N">Immunity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013961" MajorTopicYN="N">Thyroid Gland</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="N">Viruses</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Graves disease</Keyword><Keyword MajorTopicYN="N">HLA class I</Keyword><Keyword MajorTopicYN="N">STAT1</Keyword><Keyword MajorTopicYN="N">autoimmune thyroid disease</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">viral infections</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>28</Day><Hour>12</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33367784</ArticleId><ArticleId IdType="pmc">PMC7993595</ArticleId><ArticleId IdType="doi">10.1210/clinem/dgaa958</ArticleId><ArticleId IdType="pii">6047595</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lee HJ, Li CW, Hammerstad SS, Stefan M, Tomer Y. Immunogenetics of autoimmune thyroid diseases: a comprehensive review. J Autoimmun. 2015;64:82-90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4628844</ArticleId><ArticleId IdType="pubmed">26235382</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen QY, Huang W, She JX, Baxter F, Volpe R, Maclaren NK. HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves&#x2019; disease in North American Caucasians, whereas DRB1*07 is protective. J Clin Endocrinol Metab. 1999;84(9):3182-3186.</Citation><ArticleIdList><ArticleId IdType="pubmed">10487684</ArticleId></ArticleIdList></Reference><Reference><Citation>Misaki T, Iida Y, Kasagi K, Konishi J. Seasonal variation in relapse rate of Graves&#x2019; disease after thionamide drug treatment. Endocr J. 2003;50(6):669-672.</Citation><ArticleIdList><ArticleId IdType="pubmed">14709836</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammerstad SS, Stefan M, Blackard J, et al. . Hepatitis C virus E2 protein induces upregulation of IL-8 pathways and production of heat shock proteins in human thyroid cells. J Clin Endocrinol Metab. 2017;102(2):689-697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5413166</ArticleId><ArticleId IdType="pubmed">27860532</ArticleId></ArticleIdList></Reference><Reference><Citation>Desailloud R, Goffard A, Page C, et al. . Detection of enterovirus RNA in postoperative thyroid tissue specimens. Clin Endocrinol (Oxf). 2009;70(2):331-334.</Citation><ArticleIdList><ArticleId IdType="pubmed">18616703</ArticleId></ArticleIdList></Reference><Reference><Citation>Desailloud R, San&#xe9; F, Caloone D, Hober D. Persistent infection of a carcinoma thyroid cell line with coxsackievirus B. Thyroid. 2009;19(4):369-374.</Citation><ArticleIdList><ArticleId IdType="pubmed">19292692</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata K, Hara S, Nakayama Y, et al. . Epstein-Barr virus lytic reactivation induces IgG4 production by host B lymphocytes in Graves&#x2019; disease patients and controls: a subset of Graves&#x2019; disease is an IgG4-related disease-like condition. Viral Immunol. 2018;31(8):540-547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6205085</ArticleId><ArticleId IdType="pubmed">30222515</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Zhang WP, Yao L, et al. . PRDM1 expression via human parvovirus B19 infection plays a role in the pathogenesis of Hashimoto thyroiditis. Hum Pathol. 2015;46(12):1913-1921.</Citation><ArticleIdList><ArticleId IdType="pubmed">26475096</ArticleId></ArticleIdList></Reference><Reference><Citation>Caselli E, D&#x2019;Accolti M, Soffritti I, et al. . HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis. Virol J. 2017;14(1):3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5234148</ArticleId><ArticleId IdType="pubmed">28081700</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammerstad SS, Blackard JT, Lombardi A, et al. . Hepatitis C virus infection of human thyrocytes: metabolic, hormonal, and immunological implications. J Clin Endocrinol Metabol. 2019;105(4):1157-1168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7067536</ArticleId><ArticleId IdType="pubmed">31784757</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammerstad SS, Tauriainen S, Hy&#xf6;ty H, Paulsen T, Norheim I, Dahl-J&#xf8;rgensen K. Detection of enterovirus in the thyroid tissue of patients with Graves&#x2019; disease. J Med Virol. 2013;85(3):512-518.</Citation><ArticleIdList><ArticleId IdType="pubmed">23280563</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogvold L, Edwin B, Buanes T, et al. . Detection of a low-grade enteroviral infection in the islets of Langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes. 2015;64(5):1682-1687.</Citation><ArticleIdList><ArticleId IdType="pubmed">25422108</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson SJ, Leete P, Bone AJ, Foulis AK, Morgan NG. Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia. 2013;56(1):185-193.</Citation><ArticleIdList><ArticleId IdType="pubmed">23064357</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahrs CR, Chuda K, Tapia G, et al. . Enterovirus as trigger of coeliac disease: nested case-control study within prospective birth cohort. BMJ. 2019;364:l231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6372922</ArticleId><ArticleId IdType="pubmed">30760441</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Bourlet T, Andreoletti L, et al. . Enteroviral capsid protein VP1 is present in myocardial tissues from some patients with myocarditis or dilated cardiomyopathy. Circulation. 2000;101(3):231-234.</Citation><ArticleIdList><ArticleId IdType="pubmed">10645916</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RC, Doniach D, Bottazzo GF. Aberrant expression of HLA-DR antigen on thyrocytes in Graves&#x2019; disease: relevance for autoimmunity. Lancet. 1983;2(8359):1111-1115.</Citation><ArticleIdList><ArticleId IdType="pubmed">6138646</ArticleId></ArticleIdList></Reference><Reference><Citation>Farid NR, Stone E, Johnson G. Graves&#x2019; disease and hla: clinical and epidemiologic associations. Clin Endocrinol (Oxf). 1980;13(6):535-544.</Citation><ArticleIdList><ArticleId IdType="pubmed">6894412</ArticleId></ArticleIdList></Reference><Reference><Citation>Heward JM, Allahabadia A, Daykin J, et al. . Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves&#x2019; disease: replication using a population case control and family-based study. J Clin Endocrinol Metabol. 1998;83(10):3394-3397.</Citation><ArticleIdList><ArticleId IdType="pubmed">9768636</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamani M, Spaepen M, Bex M, Bouillon R, Cassiman JJ. Primary role of the HLA class II DRB1*0301 allele in Graves disease. Am J Med Genet. 2000;95(5):432-437.</Citation><ArticleIdList><ArticleId IdType="pubmed">11146462</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong RP, Kimura A, Okubo R, et al. . HLA-A and DPB1 loci confer susceptibility to Graves&#x2019; disease. Hum Immunol. 1992;35(3):165-172.</Citation><ArticleIdList><ArticleId IdType="pubmed">1363421</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmonds MJ, Howson JM, Heward JM, et al. . A novel and major association of HLA-C in Graves&#x2019; disease that eclipses the classical HLA-DRB1 effect. Hum Mol Genet. 2007;16(18):2149-2153.</Citation><ArticleIdList><ArticleId IdType="pubmed">17597093</ArticleId></ArticleIdList></Reference><Reference><Citation>Weider T, Richardson SJ, Morgan NG, Paulsen TH, Dahl-J&#xf8;rgensen K, Hammerstad SS. Upregulation of HLA class I and antiviral tissue responses in Hashimoto&#x2019;s thyroiditis. Thyroid. 2020;30(3):432-442.</Citation><ArticleIdList><ArticleId IdType="pubmed">31910110</ArticleId></ArticleIdList></Reference><Reference><Citation>Meraz MA, White JM, Sheehan KC, et al. . Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 1996;84(3): 431-442.</Citation><ArticleIdList><ArticleId IdType="pubmed">8608597</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu XY, Kessler DS, Veals SA, Levy DE, Darnell JE Jr. ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains. Proc Natl Acad Sci U S A. 1990;87(21):8555-8559.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC54995</ArticleId><ArticleId IdType="pubmed">2236065</ArticleId></ArticleIdList></Reference><Reference><Citation>Czerkies M, Korwek Z, Prus W, et al. . Cell fate in antiviral response arises in the crosstalk of IRF, NF-&#x3ba;B and JAK/STAT pathways. Nat Commun. 2018;9(1):493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5799375</ArticleId><ArticleId IdType="pubmed">29402958</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamauchi S, Takeuchi K, Chihara K, et al. . STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-&#x3bb; but not by interferon-&#x3b1;. Sci Rep. 2016;6:38336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5144079</ArticleId><ArticleId IdType="pubmed">27929099</ArticleId></ArticleIdList></Reference><Reference><Citation>Durbin JE, Hackenmiller R, Simon MC, Levy DE. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell. 1996;84(3):443-450.</Citation><ArticleIdList><ArticleId IdType="pubmed">8608598</ArticleId></ArticleIdList></Reference><Reference><Citation>Larner AC, Chaudhuri A, Darnell JE Jr. Transcriptional induction by interferon. New protein(s) determine the extent and length of the induction. J Biol Chem. 1986;261(1):453-459.</Citation><ArticleIdList><ArticleId IdType="pubmed">2934388</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler DS, Veals SA, Fu XY, Levy DE. Interferon-&#x3b1; regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes Dev. 1990;4(10):1753-1765.</Citation><ArticleIdList><ArticleId IdType="pubmed">2249773</ArticleId></ArticleIdList></Reference><Reference><Citation>Bluyssen HA, Muzaffar R, Vlieststra RJ, et al. . Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses. Proc Natl Acad Sci U S A. 1995;92(12):5645-5649.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC41753</ArticleId><ArticleId IdType="pubmed">7539922</ArticleId></ArticleIdList></Reference><Reference><Citation>Meurs EF, Watanabe Y, Kadereit S, et al. . Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J Virol. 1992;66(10):5805-5814.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC241456</ArticleId><ArticleId IdType="pubmed">1382142</ArticleId></ArticleIdList></Reference><Reference><Citation>Balachandran S, Roberts PC, Brown LE, et al. . Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity. 2000;13(1):129-141.</Citation><ArticleIdList><ArticleId IdType="pubmed">10933401</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999;17(5):1474-1481.</Citation><ArticleIdList><ArticleId IdType="pubmed">10334533</ArticleId></ArticleIdList></Reference><Reference><Citation>Effraimidis G, Tijssen JG, Wiersinga WM. Discontinuation of smoking increases the risk for developing thyroid peroxidase antibodies and/or thyroglobulin antibodies: a prospective study. J Clin Endocrinol Metab. 2009;94(4):1324-1328.</Citation><ArticleIdList><ArticleId IdType="pubmed">19141579</ArticleId></ArticleIdList></Reference><Reference><Citation>Strieder TG, Prummel MF, Tijssen JG, Endert E, Wiersinga WM. Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol (Oxf). 2003;59(3):396-401.</Citation><ArticleIdList><ArticleId IdType="pubmed">12919165</ArticleId></ArticleIdList></Reference><Reference><Citation>Belin RM, Astor BC, Powe NR, Ladenson PW. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2004;89(12):6077-6086.</Citation><ArticleIdList><ArticleId IdType="pubmed">15579761</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen IB, Laurberg P, Knudsen N, et al. . Smoking is negatively associated with the presence of thyroglobulin autoantibody and to a lesser degree with thyroid peroxidase autoantibody in serum: a population study. Eur J Endocrinol. 2008;158(3): 367-373.</Citation><ArticleIdList><ArticleId IdType="pubmed">18299471</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson SJ, Leete P, Dhayal S, et al. . Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas. Diabetologia. 2014;57(2):392-401.</Citation><ArticleIdList><ArticleId IdType="pubmed">24190581</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammerstad SS, Jahnsen FL, Tauriainen S, et al. . Immunological changes and increased expression of myxovirus resistance protein A in thyroid tissue of patients with recent onset and untreated Graves&#x2019; disease. Thyroid. 2014;24(3):537-544.</Citation><ArticleIdList><ArticleId IdType="pubmed">24032645</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson SJ, Rodriguez-Calvo T, Gerling IC, et al. . Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes. Diabetologia. 2016;59(11):2448-2458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5042874</ArticleId><ArticleId IdType="pubmed">27506584</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev. 2006;19(1):80-94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1360274</ArticleId><ArticleId IdType="pubmed">16418524</ArticleId></ArticleIdList></Reference><Reference><Citation>Akeno N, Smith EP, Stefan M, et al. . IFN-&#x3b1; mediates the development of autoimmunity both by direct tissue toxicity and through immune cell recruitment mechanisms. J Immunol. 2011;186(8):4693-4706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3106338</ArticleId><ArticleId IdType="pubmed">21402899</ArticleId></ArticleIdList></Reference><Reference><Citation>Faustino LC, Lombardi A, Madrigal-Matute J, Owen RP, Libutti SK, Tomer Y. Interferon-&#x3b1; triggers autoimmune thyroid diseases via lysosomal-dependent degradation of thyroglobulin. J Clin Endocrinol Metab. 2018;103(10):3678-3687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6179164</ArticleId><ArticleId IdType="pubmed">30113675</ArticleId></ArticleIdList></Reference><Reference><Citation>Benvenga S, Guarneri F, Vaccaro M, Santarpia L, Trimarchi F. Homologies between proteins of Borrelia burgdorferi and thyroid autoantigens. Thyroid. 2004;14(11):964-966.</Citation><ArticleIdList><ArticleId IdType="pubmed">15671776</ArticleId></ArticleIdList></Reference><Reference><Citation>Herzer K, Falk CS, Encke J, et al. . Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity. J Virol. 2003;77(15):8299-8309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC165225</ArticleId><ArticleId IdType="pubmed">12857899</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasner A, Oiknine-Djian E, Weisblum Y, et al. . Zika virus escapes NK cell detection by upregulating major histocompatibility complex class I molecules. J Virol. 2017;91(22):e00785-17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5660495</ArticleId><ArticleId IdType="pubmed">28878071</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson RK, Engdahl EE, Hammarfjord O, et al. . Human herpesvirus 6A partially suppresses functional properties of DC without viral replication. PloS One. 2013;8(3):e58122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3590851</ArticleId><ArticleId IdType="pubmed">23526966</ArticleId></ArticleIdList></Reference><Reference><Citation>Mack WP, Stasior GO, Cao HJ, Stasior OG, Smith TJ. The effect of cigarette smoke constituents on the expression of HLA-DR in orbital fibroblasts derived from patients with Graves ophthalmopathy. Ophthalmic Plast Reconstr Surg. 1999;15(4):260-271.</Citation><ArticleIdList><ArticleId IdType="pubmed">10432522</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye XP, Yuan FF, Zhang LL, et al. ; China Consortium for the Genetics of Autoimmune Thyroid Disease . ITM2A expands evidence for genetic and environmental interaction in Graves disease pathogenesis. J Clin Endocrinol Metab. 2017;102(2):652-660.</Citation><ArticleIdList><ArticleId IdType="pubmed">27809695</ArticleId></ArticleIdList></Reference><Reference><Citation>Harii N, Lewis CJ, Vasko V, et al. . Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto&#x2019;s autoimmune thyroiditis. Mol Endocrinol. 2005;19(5):1231-1250.</Citation><ArticleIdList><ArticleId IdType="pubmed">15661832</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf8;ydahl LS, Frick R, Sandlie I, L&#xf8;set G&#xc5;. Targeting the MHC ligandome by use of TCR-like antibodies. Antibodies (Basel). 2019;8(2):32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6640717</ArticleId><ArticleId IdType="pubmed">31544838</ArticleId></ArticleIdList></Reference><Reference><Citation>.Newell EW, Davis MM. Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells. Nat Biotechnol. 2014;32(2):149-157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4001742</ArticleId><ArticleId IdType="pubmed">24441473</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>